Back
SpringWorks Therapeutics Stock Price Chart
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
37
SWTX
SpringWorks Therapeutics
Last Price:
33.01
Seasonality Move:
44.81%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
SpringWorks Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.39 | Buy |
| 20-day SMA: | 30.38 | Buy |
| 50-day SMA: | 33.95 | Sell |
| 200-day SMA: | 40.57 | Sell |
| 8-day EMA: | 30.62 | Buy |
| 20-day EMA: | 30.87 | Buy |
| 50-day EMA: | 32.91 | Sell |
| 200-day EMA: | 36.43 | Sell |
SpringWorks Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.72 | Sell |
| Relative Strength Index (14 RSI): | 52.3 | Buy |
| Chaikin Money Flow: | 626793 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.68 - 31.86) | Buy |
| Bollinger Bands (100): | (32.01 - 39.33) | Sell |
SpringWorks Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for SpringWorks Therapeutics Stock
Is SpringWorks Therapeutics Stock a Buy?
- SpringWorks Therapeutics share price is 31.59 while SWTX 8-day simple moving average is 30.39, which is a Buy signal.
- The stock price of SWTX is 31.59 while SpringWorks Therapeutics 20-day SMA is 30.38, which makes it a Buy.
- SpringWorks Therapeutics 50-day simple moving average is 33.95 while SWTX share price is 31.59, making it a Sell technically.
- SWTX stock price is 31.59 and SpringWorks Therapeutics 200-day simple moving average is 40.57, creating a Sell signal.
SWTX Technical Analysis vs Fundamental Analysis
Sell
37
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy or a Sell?
-
SpringWorks Therapeutics stock is rated a Sell
The current SpringWorks Therapeutics [SWTX] share price is $31.59. The Score for SWTX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
SpringWorks Therapeutics Stock Info
Market Cap:
2.35B
Price in USD:
31.59
Share Volume:
666.46K
SpringWorks Therapeutics 52-Week Range
52-Week High:
53.92
52-Week Low:
18.00
Sell
37
SpringWorks Therapeutics (SWTX)
is a Sell
SpringWorks Therapeutics Share Price Forecast
-
What is the SpringWorks Therapeutics stock price today?
The SpringWorks Therapeutics stock price is 31.59 USD today. -
Will SWTX stock go up or go down?
SpringWorks Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is SpringWorks Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, SpringWorks Therapeutics is overvalued.
Is SpringWorks Therapeutics Stock a Buy?
- SpringWorks Therapeutics share price is 31.59 while SWTX 8-day exponential moving average is 30.62, which is a Buy signal.
- The stock price of SWTX is 31.59 while SpringWorks Therapeutics 20-day EMA is 30.87, which makes it a Buy.
- SpringWorks Therapeutics 50-day exponential moving average is 32.91 while SWTX share price is 31.59, making it a Sell technically.
- SWTX stock price is 31.59 and SpringWorks Therapeutics 200-day simple moving average is 36.43, creating a Sell signal.
Fundamental Analysis of SpringWorks Therapeutics
Is SpringWorks Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.13 per share, and an increase next year of $1.54 per share.
Technical Analysis of SpringWorks Therapeutics
Should I short SpringWorks Therapeutics stock?
- SWTX Moving Average Covergence Divergence (MACD) indicator is -0.72, suggesting SpringWorks Therapeutics is a Sell
- SpringWorks Therapeutics Relative Strength Index (RSI) is 52.3, which suggest SpringWorks Therapeutics is overbought
- The Bollinger Bands (25) for SpringWorks Therapeutics is (29.68 - 31.86), which suggest SpringWorks Therapeutics is a Sell
- The Bollinger Bands (100) for SpringWorks Therapeutics is (32.01 - 39.33), which suggest SpringWorks Therapeutics is a Sell
* SpringWorks Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.